Carmichael Roberts, PhD
Executive Chairman

Carmichael Roberts is the Executive Chairman of Arsenal Medical and a General Partner at North Bridge Venture Partners. Prior to this role, he co-founded and served as the President and Chief Executive Officer of the Company. Before Arsenal Medical, Carmichael co-founded and served as the President and Chief Executive Officer of Surface Logix, Inc., a drug optimization company. Carmichael has also co-founded and served as a director of several other ventures, including Ancora Pharmaceuticals, Inc., a carbohydrate materials company, Nano-Terra, Inc., an electronics and industrial materials company, and Diagnostics For All, Inc., a non-profit organization that is developing a materials platform to make low cost diagnostics for the poor.

Prior to his entrepreneurial career, Carmichael worked in business development at GelTex Pharmaceuticals, Inc., which was acquired by Genzyme for $1.3 billion. Prior to GelTex, Carmichael was responsible for new product and business development in the Sentry Products Specialty Materials Division of Union Carbide Corporation.

Carmichael received his B.S. and Ph.D. in organic chemistry from Duke University and completed his postdoctoral fellowship at Harvard University. Carmichael also received his M.B.A. from the MIT Sloan School of Management.